Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome Maps to Chromosome 22q13.32-qter  by Hirano, Michio et al.
Am. J. Hum. Genet. 63:526–533, 1998
526
Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome Maps
to Chromosome 22q13.32-qter
Michio Hirano,1 Justo Garcia-de-Yebenes,1,3 Alison C. Jones,1 Ichizo Nishino,1
Salvatore DiMauro,1 Jose´ R. Carlo,4 Adam N. Bender,2 Angelica F. Hahn,5 Larry M. Salberg,6
Daniel E. Weeks,7,8 and Torbjoern G. Nygaard1
1Department of Neurology, Columbia University College of Physicians and Surgeons, and 2Department of Neurology, Mount Sinai School of
Medicine, New York; 3Department of Neurology, University of Madrid, Madrid; 4University of Puerto Rico School of Medicine, San Juan;
5Department of Clinical Neurology, University of Western Ontario, London, Ontario; 6Department of Neurology, Cleveland Clinic Foundation,
Cleveland; 7Department of Genetics, University of Pittsburgh, Pittsburgh; and 8The Wellcome Trust Centre for Human Genetics, Oxford
Summary
Mitochondrial neurogastrointestinal encephalomyopa-
thy (MNGIE) syndrome is a rare, multisystem disorder
characterized clinically by ptosis, progressive external
ophthalmoplegia, gastrointestinal dysmotility, leukoen-
cephalopathy, thin body habitus, and myopathy. Lab-
oratory studies reveal defects of oxidative-phosphory-
lation and multiple mtDNA deletions frequently in
skeletal muscle. We studied four ethnically distinct fam-
ilies affected with this apparently autosomal recessive
disorder. Probands from each family were shown, by
Southern blot, to havemultiple mtDNAdeletions in skel-
etal muscle. We mapped the MNGIE locus to 22q13.32-
qter, distal to D22S1161, with a maximum two-point
LOD score of 6.80 at locus D22S526. Cosegregation of
MNGIE with a single chromosomal region in families
with diverse ethnic backgrounds suggests that we have
mapped an important locus for this disorder. We found
no evidence to implicate three candidate genes in this
region, by using direct sequence analysis for DNA hel-
icase II and by assaying enzyme activities for arylsul-
fatase A and carnitine palmitoyltransferase.
Introduction
Mitochondrial encephalomyopathies encompass a grow-
ing number of distinct clinical syndromes that are the
result of defects in mitochondrial oxidative-phosphor-
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ylation enzymes (DiMauro and Bonilla 1997). Those
enzymes are assembled from subunits encoded in both
mtDNA and nuclear DNA (nDNA). mtDNA is a double-
stranded, circular molecule comprising 16,569 base
pairs that encode 22 tRNA, 2 rRNA, and 13 polypep-
tide genes (Anderson et al. 1981). Of the 13 mtDNA-
encoded polypeptides, 7 are subunits of complex I
(NADH–coenzyme [Co] Q oxidoreductase), 1 of com-
plex III (CoQ–cytochrome c oxidoreductase), 3 of com-
plex IV (cytochrome c oxidase [COX]), and 2 of com-
plex V (ATP synthase) (Attardi and Schatz 1988).
Although the mtDNA-encoded subunits are vastly out-
numbered by the ∼1,000 mitochondrial polypeptides en-
coded in nDNA, to date the majority of mitochondrial
encephalomyopathies have been associated with
mtDNA mutations (Schon et al. 1997). Mutations in
nDNA constitute a second cause of mitochondrial dys-
function; however, to date, only two nDNA mutations
have been associated with defects in oxidative phos-
phorylation: one in the flavoprotein subunit of succinate
dehydrogenase (complex II) (Bourgeron et al. 1995) and
the other in the 18-kD (AQDQ) subunit of complex I
(van den Heuvel et al. 1998). A third group of genetic
mitochondrial disorders includes defects of intergenomic
communication, presumably due to mutations of nDNA
genes controlling replication and expression of the mi-
tochondrial genome. The first intergenomic communi-
cation defect to be identified was autosomal dominant
progressive external ophthalmoplegia (PEO), which was
associated with multiple mtDNA deletions (Zeviani et
al. 1989). This disorder has been mapped to two chro-
mosomal regions, 10q23.3–24.3 and 3p14.1–21.2
(Suomalainen et al. 1995; Kaukonen et al. 1996). Wolf-
ram syndrome, a second disorder associated with mul-
tiple mtDNA deletions in two families, is an autosomal
recessive neurodegenerative condition clinically charac-
terized by diabetes insipidus, insulin-dependent diabetes
mellitus, optic atrophy, and deafness, and it has been
linked to chromosomal markers at 4p16 (Barrientos et
al. 1996).
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Mitochondrial neurogastrointestinal encephalomy-
opathy (MNGIE), or myoneurogastrointestinal enceph-
alopathy syndrome (MIM 550900; Genome Database
accession number 9835128), is a multisystem disorder
clinically characterized by onset between the 2d and 5th
decades of life, ptosis, PEO, gastrointestinal dysmotility
(often pseudo-obstruction), diffuse leukoencephalopa-
thy, thin body habitus, peripheral neuropathy, and my-
opathy, with a presumed autosomal recessive inheritance
pattern (Bardosi et al. 1987; Hirano et al. 1994). Au-
tosomal recessive inheritance has been inferred because
of (1) the high recurrence rate among siblings (14 of 49
siblings of probands), (2) the lack of affected parents
and progeny, and (3) the relatively high rate of consan-
guinity (4/19 families) (Hirano et al. 1994; this report).
To date, fewer than 50 MNGIE patients, of various eth-
nic backgrounds, have been identified (Hirano et al.
1994). Laboratory studies demonstrate oxidative-phos-
phorylation defects, including lactic acidosis, ragged-red
fibers in skeletal muscle biopsies, ultrastructurally ab-
normal mitochondria, and decreased activities of the mi-
tochondrial electron-transport enzymes. The underlying
nDNA defect in MNGIE is unknown; however, MNGIE
often is associated with multiple mtDNA deletions. The
observation of multiple mtDNA deletions in this dis-
order suggests that the autosomal defect may disrupt
intergenomic communication.
In order to identify the chromosomal locus responsible
for MNGIE, we screened the entire autosomal genome
in two families, using simple-sequence–repeat (SSR)
markers and linkage analysis. We then confirmed our
finding by analyzing two additional families.
Subjects and Methods
Clinical Characterization
All individuals who were genotyped were examined
by at least one neurologist. The diagnosis of MNGIE
was made only for individuals 120 years of age who had
the following four clinical features: (1) thin body hab-
itus; (2) ptosis, ophthalmoparesis, or both; (3) gastro-
intestinal dysmotility (chronic diarrhea or pseudo-ob-
struction); and (4) sensorimotor peripheral neuropathy
(stocking-glove sensory loss, absent tendon reflexes, dis-
tal limb weakness, and wasting) (Hirano et al. 1994).
Laboratory studies of at least one affected individual in
each family showed diffuse leukodystrophy (increased
T2 signal on brain magnetic-resonance imaging); nerve
conduction abnormalities with features consistent with
demyelination, axonal degeneration, or both; skeletal
muscle biopsy revealing neurogenic changes, ragged-red
fibers, and COX-deficient fibers; and multiple mtDNA
deletions.
Individuals V-1 and V-2 in family 3 died prior to the
start of this study. Photographic and medical records
confirmed the information, obtained from other family
members, that both sisters suffered from the same dis-
order as their cousin, individual V-4 (fig. 1). Photographs
of the sisters when they were in their 20s confirmed that
both were very thin and had ptosis. Both had gastro-
intestinal dysmotility and died several days after gastro-
intestinal surgery.
Genotyping
Total leukocyte DNA was extracted by use of standard
proteinase K, phenol-chloroform, and ethanol precipi-
tation techniques (Zeviani et al. 1988). The DNA was
genotyped by use of PCR-amplified fragments contain-
ing mapped SSR polymorphisms. For each reaction, 85
ng template DNA was amplified in microtiter wells in a
total volume of 10 ml containing 1–2 pmol of each
primer, 0.02 mM of each dNTP, 10 mM Tris-HCl (pH
8.8), 50 mM KCl, 1.5 mM MgCl2, and 0.5 U Taq poly-
merase. One primer was 5′-labeled by use of g[32P]-dATP
and T4 polynucleotide kinase. The radiolabeled DNA
fragments were electrophoresed on a 5% denaturing
polyacrylamide gel (Long Ranger, FMC BioProducts),
which was exposed to Kodak BioMax film.
For families 1 and 2, we tested 398 SSR markers dis-
tributed across the entire human autosomal genome and
spaced, on average, at 10-cM intervals. For the final
analysis, we tested 21 SSR markers on chromosome 22,
in all four families.
Linkage Analyses
Two-point (marker to disease) analyses were per-
formed by use of the MLINK option of FASTLINK 4.0
(Cottingham et al. 1993; Becker et al. 1998). The data
were read by at least two individuals blind to subject
identity and disease status. Data not consistent with
Mendelian inheritance were reinspected and repeated, if
necessary. In addition, data for entire chromosomes were
analyzed by use of SIMWALK2, which uses simulated
annealing to derive individual haplotypes with a mini-
mum of recombination events (Sobel et al. 1995; Sobel
and Lange 1996). Data for individuals or markers that
caused apparent high-order recombination events were
also reinspected, repeated, or both. Multipoint (at least
two markers to disease) analyses were performed by use
of the LINKMAP option. We used an autosomal reces-
sive model with a disease penetrance of 95%, a disease
frequency of 1 per 4 million, and a phenocopy rate of
1 per 4 billion. Marker allele frequencies were estimated
by allele counting with all genotyped subjects.
Marker Mapping
We genotyped 61 families of the CEPH reference col-
lection (Dausset et al. 1990), using the methodology de-
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Figure 1 Pedigrees for MNGIE families. Probands are indicated by the arrows. Blackened symbols indicate affected individuals. Genotypes
and inferred haplotypes are listed below the symbol for an individual. Haplotypes shared among the affected individuals and their parents are
boxed.
scribed above. Map construction was performed by use
of Multimap (Matise et al. 1994), with error checking
following the protocol we used previously (Weeks et al.
1995). Radiation-hybrid (RH) mapping was performed
by use of the Stanford G3 and the Stanford TNG3 RH
panels (Research Genetics).
DNA Helicase II Analysis
Using the cDNA sequence for human DNA helicase
II (Ku protein p70 subunit) (Chan et al. 1989; Reeves
and Sthoeger 1989), we searched the databases, using
the National Center for Biotechnology Information Ba-
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Figure 2 Three-point LOD scores based on genotype data from
all four MNGIE families, for markers D22S1149, D22S1170,
D22S1161, D22S922, D22S1169, JCW16, and D22S526, which were
mapped across a 22.1-cM region on 22q13.32-qter. The maximum
LOD score was 7.51 at D22S526. A LOD score of12.4 at D22S1149
indicates a recombination between this locus and the gene for MNGIE.
sic Local Alignment Search Tool. We found DNA se-
quence fragments within the genomic clone 216E10
(submitted by the Wellcome Trust Genome Campus) that
were identical to helicase II p70 subunit cDNA se-
quences. The complete cDNA sequence was arranged in
13 exons with corresponding intron splice sequences. In
addition, we found a 3′ UTR with the polyadenylation
signal and promoter regions with one CCAAT and three
GC-box sequences (M. Hirano and P. Magalhaes, un-
published data). We designed 12 primer pairs flanking
the 13 exons and 4 additional primers, to amplify the
gene promoter region (M. Hirano and P. Magalhaes,
unpublished data). We amplified all 13 exons and the
promoter regions of an affected and an unaffected sibling
in family 1 (individuals IV-1 and IV-5, respectively) and
of the probands from the other three families. The PCR
products were electrophoresed in 2% low–melting-point
agarose gels, were excised by cutting the gel containing
the band, and were isolated by use of the Qiaex II Gel
Purification kit (Qiagen).
We identified three tandem-repeat sequences in the
216E10 genomic clone containing the helicase II
gene—namely, two dinucleotide-repeat elements and one
trinucleotide-repeat element. Two were previously iden-
tified SSRs, D22S1267 (ATA5F05) and D22S276
(AFM165za5). Genotyping and linkage analyses of all
four MNGIE families were performed by use of the
methods described above.
Results
Clinical Description
The four families have distinct ethnic origins: family
1 is Ashkenazi Jewish; family 2 is German American;
family 3 is Puerto Rican; and family 4 is African Amer-
ican. In two families, affected individuals were offspring
of consanguinous marriages (fig. 1). Table 1 lists the
major clinical features of the affected family members.
The proband in each family had the following clinical
features: ptosis, ophthalmoparesis, peripheral neuropa-
thy, myopathy, gastrointestinal dysmotility, and thin
body habitus. Ten members of these families fulfilled the
four diagnostic criteria for MNGIE (see Subjects and
Methods), and 25 members were completely unaffected.
Two deceased members in family 3 also fulfilled the di-
agnostic criteria for MNGIE, on the basis of a review
of their medical histories and records. The affected
brothers in family 2 were reported elsewhere as patients
4 and 5 (Hirano et al. 1994).
In each proband, skeletal muscle biopsy revealed rag-
ged-red fibers and COX-deficient fibers. Southern blot
analyses of the skeletal muscle biopsies, by use of re-
striction enzymes BamHI and PvuII, revealed multiple
mtDNA deletions. Further analyses of skeletal muscle
biopsies of two patients (IV-4 in family 1 and V-4 in
family 3) have been reported (Carrozzo et al. 1998).
Following digestion with each of three restriction en-
zymes—PvuII, BamHI, and SnaBI—Southern blot anal-
ysis of skeletal muscle showed multiple mtDNA dele-
tions without duplications; the deletions represented 6%
(patient IV-4 in family 1) and 20% (patient V-4 in family
3) of the total mtDNA (Carrozzo et al. 1998).
Linkage Studies
For our initial screening, we genotyped 10 members
of family 1 and 6 members of family 2, using 398 poly-
morphic SSR markers distributed across the human au-
tosomal genome, at ∼10-cM intervals. By multipoint
analysis, we excluded 190% of the autosomal genome
(LOD scores X2.0) as the potential locus for MNGIE
in families 1 and 2. The largest chromosomal region that
was not excluded was 17 cM (except for the chromo-
somal region linked to the disease). We identified five
loci yielding two-point LOD scores x1.0. Subsequent
evaluation of these regions, with additional markers and
multipoint analyses, excluded linkage to all but one re-
gion, at the telomere of chromosome 22q.
For the final analyses, we genotyped all four families,
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Table 1
Clinical Features of MNGIE Patients
Family (Ethnic
Origin) and
Patient
Age
(years)
Age at Onset
(years) Ophthalmoparesis
Peripheral
Neuropathy
Gastrointestinal
Dysmotility
Multiple
mtDNA
Deletions
1 (Ashkenazi Jewish):
IV-1 49 32    Not tested
IV-3a 45 43   
IV-6 40b 35    Not tested
IV-7 39 29    Not tested
2 (German American):
II-1a 26 19    
II-2a 25 20    
3 (Puerto Rican):
V-1 25b 18    Not tested
V-2 Unknownb Unknown    Not tested
V-4a 34 24    
4 (African American):
II-1 27 Unknown    Not tested
II-3a 23 Unknown    
II-5 13 13    Not tested
NOTE.—A plus sign () indicates presence of the clinical feature.
a Proband.
b Patient died at age indicated.
with 21 markers on chromosome 22. The maximum
two-point LOD score was 6.80 with marker D22S526,
with no recombinations (table 2). Three-point analysis
of the genotype data resulted in a maximum LOD score
of 7.51 at D22S526 (fig. 2). The disease region was
flanked proximally by an obligate recombination event
in family 3, at D22S1161 (table 2).
The genetic map of the telomeric region of 22q is
poorly defined. To determine the order of the seven
markers across the linked region and to define its bound-
aries, we used these markers to create a high-resolution
genetic map, by genotyping the extended CEPH refer-
ence collection (61 families; 1,032 meioses) (table 3 in
Dausset et al. 1990). This order was supported by odds
11020 over any other order and places D22S526 distal
to JCW16. The observed paternal recombination rate
for the distal two markers was more than sixfold the
maternal rate, which is consistent with observations of
other telomeric regions. The genetic map order was also
supported by the RH-mapping data, with odds 1200:1,
by use of the Stanford G3 and the Stanford TNG3 RH
panels. The detailed genetic map then was used in mul-
tipoint analyses. Our results suggest that MNGIE is lo-
cated in the telomeric region of chromosome 22q, distal
to D22S1161.
Candidate-Gene Evaluation
Of 34 cDNA markers within our candidate region
(D22S1149 to 22qter) (Schuler et al. 1996), we identified
three human genes of known functions: arylsulfatase A,
carnitine palmitoyltransferase I (CPTI), and ATP-depen-
dent DNA helicase II. We considered all three as poten-
tial candidate genes for MNGIE.
To examine the gene for carnitine palmitoyltransfer-
ase, we measured enzyme activity in total muscle ho-
mogenates from probands IV-4 in family 1 and V-4 in
family 3; both were normal (data not shown). Leukocyte
arylsulfatase activity was normal in patients IV-1 in fam-
ily 1, II-1 and II-2 in family 2, and V-4 in family 3 (data
not shown).
In our efforts to identify the genomic sequence of hel-
icase II, we detected two previously identified tandem-
repeat sequences, D22S1267 (ATA5F05) and D22S276
(AFM165za5), adjacent to the gene. We had genotyped
these SSR markers as part of our MNGIE linkage efforts
and were able to exclude the helicase gene in two families
(1 and 3) by linkage alone. In the index patients of all
four families, we sequenced the 13 exons of the helicase
gene, all intron/exon (GT/AT) splice junctions, 1,609
nucleotides 5′ of the first exon (which included one
CCAAT and three GC boxes), and 24 nucleotides 3′ of
the polyadenylation signal. We found no mutations in
the genomic DNA sequence.
Discussion
To date, no human gene has been identified as a cause
of multiple mtDNA deletions. Our study demonstrates
a chromosomal locus for MNGIE located in the 10.6-
cM telomeric region of the long arm of chromosome 22
(22 q13.32-qter), distal to locus D22S1161. Our iden-
tification of a single chromosomal region that cosegre-
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Table 2
Two-Point LOD Scores for Chromosome 22q Markers and MNGIE Region, with Sex-Averaged Relative Map Locations Based on the
Extended (61 Families) CEPH Reference Collection
MARKER (RELATIVE
DISTANCE [IN CM])
AND FAMILY
LOD SCORE AT RECOMBINATION FRACTION OF
.00 .01 .05 .10 .20 .30 .40
D22S532: 10.70 .36 .78 1.05 .98 .64 .25
1 11.81 1.44 .20 .20 .39 .31 .13
2 .19 .19 .16 .13 .07 .03 .01
3 .46 .45 .39 .32 .19 .10 .04
4 .84 .82 .75 .66 .46 .26 .08
D22S1160: .81 .29 .77 .82 .65 .38 .12
1 .18 .18 .15 .11 .06 .02 .01
2 .01 .01 .01 .01 .00 .00 .00
3 1.82 .70 .12 .06 .13 .10 .04
4 .84 .82 .75 .66 .46 .26 .08
D22S1149 (0): 9.50 .81 1.82 1.94 1.59 1.01 .41
1 11.33 .96 .25 .61 .70 .53 .26
2 .22 .21 .19 .16 .10 .04 .01
3 .60 .58 .48 .38 .21 .10 .03
4 1.44 1.41 1.28 1.12 .78 .43 .13
D22S1170 (6.4): 4.59 4.50 4.14 3.68 2.72 1.69 .66
1 2.89 2.84 2.62 2.34 1.75 1.11 .46
2 .21 .20 .18 .14 .08 .03 .01
3 .46 .45 .39 .32 .21 .13 .06
4 1.44 1.41 1.30 1.16 .83 .48 .15
D22S1161 (11.5): 2.62 3.72 3.93 3.64 2.72 1.66 .62
1 2.76 2.71 2.51 2.24 1.68 1.07 .44
2 .96 .93 .84 .71 .48 .25 .07
3 1.94 .75 .16 .03 .11 .08 .03
4 .84 .82 .75 .66 .46 .26 .08
D22S922 (11.5): 3.56 3.48 3.15 2.75 1.93 1.13 .42
1 1.84 1.80 1.65 1.46 1.07 .67 .29
2 .72 .70 .63 .53 .35 .18 .05
3 .16 .15 .13 .10 .05 .02 .01
4 .84 .82 .75 .66 .46 .26 .08
D22S1169 (13.7): 5.38 5.26 4.78 4.17 2.93 1.71 .62
1 2.62 2.57 2.38 2.13 1.59 1.01 .40
2 .65 .64 .58 .50 .34 .18 .05
3 1.27 1.23 1.08 .89 .54 .26 .08
4 .84 .82 .75 .66 .46 .26 .08
JCW16 (16.4): 6.50 6.35 5.76 5.01 3.47 1.98 .68
1 2.66 2.61 2.41 2.15 1.59 .99 .37
2 .96 .93 .81 .66 .39 .18 .05
3 1.44 1.40 1.24 1.04 .65 .33 .11
4 1.44 1.41 1.30 1.16 .83 .48 .15
D22S526 (22.1): 6.80 6.65 6.04 5.27 3.68 2.15 .82
1 3.03 2.98 2.76 2.47 1.86 1.22 .54
2 .96 .93 .81 .66 .39 .18 .05
3 1.37 1.33 1.17 .97 .59 .27 .08
4 1.44 1.41 1.30 1.16 .83 .48 .15
NOTE.—Underlined numbers indicate LOD scores derived from all four families with no recombinations.
gates with MNGIE in four families of different ethnic
origins strongly supports the concept that one nDNA
gene is responsible for this disorder. The localization of
this gene is distinct from those for autosomal dominant
PEO and autosomal recessive Wolfram syndrome with
multiple mtDNA deletions (Suomalainen et al. 1995;
Barrientos et al. 1996; Kaukonen et al. 1996).
We considered each of the three identified human
genes within 22q13.32-qter as candidates. Arylsulfatase
A deficiency is the cause of metachromatic leukodystro-
phy. Because cerebral leukodystrophy and peripheral
neuropathy with demyelination are prominent features
of MNGIE, arylsulfatase A deficiency could account for
these features of the disease. However, normal arylsul-
fatase A activity in leukocytes and absence of meta-
chromatic deposits in peripheral-nerve biopsies from
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MNGIE patients indicate that arylsulfatase A is unlikely
to cause MNGIE (Hirano et al. 1994).
CPTI is located in the inner side of the outer mito-
chondrial membrane and is crucial for lipid metabolism.
Specifically, CPTI catalyzes the transport of long-chain
and very-long–chain acyl-CoA molecules across the in-
ner mitochondrial membrane, by esterization of those
molecules to acylcarnitine and with the release of free
CoA. Patients with CPTI deficiency have presented with
infantile hypoketotic hypoglycemia or, less commonly,
with myopathy (Hirano and DiMauro, in press). Skeletal
muscle from MNGIE patients showed normal carnitine
palmitoyltransferase activity, indicating that this gene
product probably is not the cause of the disorder. More-
over, because the CPTI isoform located on chromosome
22q13.3 is expressed predominantly in skeletal and heart
muscle, a mutation in the CPTI gene is unlikely to cause
a multisystem disorder such as MNGIE (Yamazaki et al.
1996).
The 70-kD subunit of ATP-dependent DNA helicase
II potentially is the strongest candidate, because it is a
DNA-binding protein that is involved in nDNA repli-
cation, transcription, repair, and recombination (Vish-
wanatha et al. 1995). According to one report, helicase
II may be found in cytosol and the nucleus; therefore,
it could have a role in intergenomic communication
(Vishwanatha et al. 1995). However, by both linkage
analysis of two of the families and by direct sequence
analysis of all four families, we excluded this gene.
Although our investigation of candidate genes has not
revealed the underlying nDNA defect in MNGIE, we
have restricted the search to the portion of 22q distal to
D22S1161 and have provided a detailed genetic frame-
work for future studies. Examination of the inferred hap-
lotypes for family 3 (fig. 1) reveals that the proband
(V-4) and his paternal aunt (IV-2), who is an obligate
carrier, share a haplotype only for markers distal to
D22S1161. This obligate recombination event defines
the proximal boundary of the MNGIE region.
The localization of MNGIE contributes to our nascent
but growing understanding of the intergenomic com-
munication between the nDNA and mtDNA. Ultimately,
identification of the gene responsible for MNGIE and
other autosomally inherited multiple mtDNA-deletion
syndromes will provide much insight into the interac-
tions between these genomes.
Acknowledgments
The authors thank the families who cooperated with this
study, Drs. Hong Shen and Caiping Chen for technical assis-
tance, and Dr. Hiroshi Mitsumoto for his kind assistance with
family 2. The study was supported by National Institutes of
Health (NIH) grants K08-NS01617 and RO1-HL59657 (to
M.H.), NS32035 (to T.G.N.), and RR11126 (to J.R.C.); the
Columbia-Presbyterian Irving Scholars Program (support to
M.H.); and the University of Pittsburgh and The Wellcome
Trust Centre for Human Genetics (support to D.E.W.).
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Genome Database, http://www.gdb.org/ (for MNGIE
[9835128])
Online Mendelian Inheritance in Man (OMIM), http://
www.ncbi.nlm.nih.gov/Omim (for MNGIE [MIM 550900])
References
Anderson S, Bankier AT, Barrel BG, DeBruijn M, Coulson AR,
Drouin J, Eperon IC, et al (1981) Sequence and organization
of the human mitochondrial genome. Nature 290:457–465
Attardi G, Schatz G (1988) Biogenesis of mitochondria. Annu
Rev Cell Biol 4:289–333
Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede
R, Goebel H, Kohlschutter A, et al (1987) Myo-, neuro-,
gastrointestinal encephalopathy (MNGIE syndrome) due to
partial deficiency of cytochrome-c-oxidase. A new mito-
chondrial multisystem disorder. Acta Neuropathol (Berl) 74:
248–258
Barrientos A, Volpini V, Casademont J, Genis D, Manzanares
J-M, Ferrer I, Carral J, et al (1996) A nuclear defect in the
4p16 region predisposes to multiple mitochondrial DNA
deletions in families with Wolfram syndrome. J Clin Invest
97:1570–1576
Becker A, Geiger D, Scha¨ffer A (1998) Automatic selection of
loop breakers for genetic linkage analysis. Hum Hered 48:
49–60
Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bour-
geois M, Viegas-Pe´quignot E, Munnich A, et al (1995) Mu-
tation of a nuclear succinate dehydrogenase gene results in
mitochondrial respiratory chain deficiency. Nat Genet 11:
144–149
Carrozzo R, Hirano M, Fromenty B, Casali C, Santorelli FM,
Bonilla E, DiMauro S, et al (1998) Multiple mtDNA dele-
tions features in autosomal dominant and recessive diseases
suggest distinct pathogeneses. Neurology 50:99–106
Chan JYC, Lerman MI, Prabhakar BS, Isozaki O, Santisteban
P, Kuppers RC, Oates EL, et al (1989) Cloning and char-
acterization of a cDNA that encodes a 70-kDa novel human
thyroid autoantigen. J Biol Chem 264:3651–3654
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster se-
quential genetic linkage computations. Am J Hum Genet 53:
252–263
Dausset J, Cann H, Cohen D, Lathrop M, Lalouel J-M, White
R (1990) Centre d’Etude du Polymorphisme Humain
(CEPH) collaborative genetic mapping of the human ge-
nome. Genomics 6:575–577
DiMauro S, Bonilla E (1997) Mitochondrial encephalomy-
opathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barch
RL (eds) The molecular and genetic basis of neurological
disease. Butterworth-Heinemann, Boston, pp 201–235
Hirano M, DiMauro S. Metabolic myopathies. In: Younger
Hirano et al.: MNGIE Syndrome Maps to 22q13.32-qter 533
DS (ed) The motor disorders. Lippincott-Raven, New York
(in press)
Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bon-
illa E, Hays AP, et al (1994) Mitochondrial neurogastroin-
testinal encephalomyopathy (MNGIE): clinical, biochemi-
cal, and genetic features of an autosomal recessive
mitochondrial disorder. Neurology 44:721–727
Kaukonen JA, Amati P, Suomalainen A, Ro¨tig A, Piscaglia M-
G, Salvi F, Weissenbach J, et al (1996) An autosomal locus
predisposing to multiple deletions of mtDNA on chromo-
some 3p. Am J Hum Genet 58:763–769
Matise TC, Perlin M, Chakravarti A (1994) Automated con-
struction of genetic linkage maps using an expert system
(multimap)—a human genome linkage map. Nat Genet 6:
384–390
Reeves WH, Sthoeger ZM (1989) Molecular cloning of cDNA
encoding the p70 (Ku) lupus autoantigen. J Biol Chem 264:
5047–5052
Schon EA, Bonilla E, DiMauro S (1997) Mitochondrial DNA
mutations and pathogenesis. J Bioenerg Biomembr 29:
131–149
Schuler GD, Boguski MS, Stewart EA, Stein LD, Byapay G,
Rice K, White RE, et al (1996) A gene map of the human
genome. Science 274:540–546
Sobel E, Lange K (1996) Descent graphs in pedigree analysis:
applications to haplotyping, location scores, and marker-
sharing statistics. Am J Hum Genet 58:1323–1337
Sobel E, Lange K, O’Connell J, Weeks D (1995) Haplotyping
algorithms. In: Speed T, Waterman M (eds) Genetic mapping
and DNA sequencing. Vol. 81 in: Friedman A, Gulliver R
(eds) IMA volumes in mathematics and its applications.
Springer-Verlag, New York, pp 89–110
Suomalainen A, Kaukonen J, Amati P, Timonen R, Haltia M,
Weissenbach J, Zeviani M (1995) An autosomal locus pre-
disposing to deletions of mtDNA. Nat Genet 9:146–151
van den Heuvel L, Ruitenbeek W, Smeets R, Gelman-Kohan
Z, Elpeleg O, Loeffen J, Trijbels F, et al (1998) Demonstra-
tion of a new pathogenic mutation in human complex I
deficiency: a 5-bp duplication in the nuclear gene encoding
the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262–268
Vishwanatha JK, Tauer TJ, Rhode SLI (1995) Characterization
of the HeLa cell single-stranded DNA-dependent ATPase/
DNA helicase II. Mol Cell Biochem 146:121–126
Weeks DE, Nygaard TG, Neystat M, Harby LD, Wilhelmsen
KC (1995) A high-resolution genetic linkage map of the
pericentromeric region of the human X chromosome. Ge-
nomics 26:39–46
Yamazaki N, Shinohara Y, Shima A, Yamanaka Y, Terada H
(1996) Isolation and characterization of cDNA and genomic
clones encoding human muscle type carnitine palmitoyl-
transferase I. Biochim Biophys Acta 1307:157–161
Zeviani M, Moraes CT, DiMauro S (1988) Deletions of mi-
tochondrial DNA in Kearns-Sayre syndrome. Neurology 38:
1339–1346
Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S,
DiDonato S (1989) An autosomal dominant disorder with
multiple deletions of mitochondrial DNA starting at the D-
loop region. Nature 339:309–311
